Radium 223 in times of COVID-19

2020, Number 3

Rev Mex Urol 2020; 80 (3)

Barreiro D, Mena CD

Language: Spanish
References: 5
Page: 1-3
PDF size: 96.38 Kb.

Text Extraction

No abstract.

REFERENCES

Berthold DR, Pond GR, Soban F, de Wit R, Eisenberger M, Tannock IF. Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study. JCO. 2008;26(2):242–5. doi: 10.1200/JCO.2007.12.4008
European Association of Urology. EAU Guidelines Office Rapid Reaction Group: An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID era. European Association of Urology. Available from: https://uroweb.org/guideline/ covid-19-recommendations/?type=appendicespublications,
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Am J Clin Pathol. 2012;137(4):516–42. doi: 10.1309/AJCPTGD94EVRSJCG
Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013 Jul 18;369(3):213– 23. doi: 10.1056/NEJMoa1213755
Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DLJ. Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis. J Natl Cancer Inst. 2015;108(5). doi: 10.1093/jnci/djv380